You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application for subcutaneous Lu...
18 June 2026 - US healthcare company Organon (NYSE:OGN) and South Korean biopharmaceutical company Samsung Bioepis Co Ltd announced on Thursday an expansion of their development and commercialisation agreement, granting Organon exclusive commercialis...
18 June 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (NASDAQ:IDYA) announced on Wednesday that its board of directors has elected Yujiro S. Hata as chairman of the board.Hata is currently president and chief executive officer, an...
18 June 2026 - Swedish clinical-stage pharmaceutical company Gesynta Pharma AB announced on Wednesday that 50% of the target of 190 patients have been randomised in its Phase 2 clinical proof-of-concept trial, NOVA.The study is evaluating vipoglansta...
17 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) confirmed on Wednesday that it has completed the acquisition of Perfuse Therapeutics Inc.Through this acquisition Bayer now holds full rights to PER-001, a...
17 June 2026 - Medical radioisotopes manufacturer Niowave Inc and Ratio Therapeutics Inc, a clinical-stage pharmaceutical company developing radiopharmaceuticals for cancer treatment, announced on Tuesday a supply agreement for Actinium-225.Under thi...